TS03 Inc Trust Units TSTIF

RE:RE:RE:RE:RE:Sum It All Up

[binjo222]

Drrwong, appreciate your last couple of posts (as I think many of us do) and please don't feel 'everyone seems against you.'  You have laid out a well reasoned criteria for both the bull and bear case.  Just seems the bears are quicker on the response trigger.

Like you I am a bull, but realize it is going to take a while.  Sterilizers are not an 'impulse buy' for a hospital.  Most hospitals have committees to oversee capital purchases.  Committee work takes time (unfortunately).  However, I would tweak one of the points you made in the bull case just a little.  The FDA didn't just approve the 510(k), they went way beyond it.  The 510(k)s were submitted for two duo-scopes (one Pentax, one Olympus).  The FDA came back with a clearance for a range of scopes that fall within a criteria.  That's a stunning endorsement of TSO3's technology. 

Also, you noted those with a short term horizon won't see much change and that a horizon of 1 to 3 years is needed.  I agree, but does TSO3 have that time horizon?  The big players in sterilization know the problems with super bugs transmitted via endoscopes and can see the FDA's obvious endorsement of TSO3 as the answer.  I suspect the player that wants to own this part of the market will be making a run at us in the near future.  A low-ball take out is probably TSO3's biggest danger.  

For those who are interested, TSO3 was mentioned today (Tuesday) on BNN Bloomberg.  James Hodgins of Curvature Hedge Strategies took a call on 12:00 Market Call.  He only spent about a minute and displayed a real ignorance of the company.  He described it as making "really fancy dishwashers for hospitals."  He stated TSO3 has "lost its partnership with Getinge."   His company is short the stock and he stated "...what's it worth? Nobody knows."  

James Hodgins probably represents the mind set of PMs who don't know much about the healthcare field, but think they do.